Gene expression analysis suggested the potential of NLRP3 inflammasome modulation to counterbalance breast cancer cells growth by activating the immunogenic cell death (pyroptosis) and inhibiting the activity of pro-inflammatory cytokines, IL-1β and IL-18 (Fig. 4). This evidence concerns the gene NLRP3 and breast carcinoma.